Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate

Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate


    • Product Name Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate
    • Alias CHA-412
    • Einecs EINECS 695-723-1
    • Mininmum Order 5mg
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    364530

    Chemical Formula C15H12N2O3S
    Molecular Weight 296.33 g/mol
    Appearance Solid (usually white or off - white powder)
    Solubility In Water Poorly soluble
    Solubility In Organic Solvents Soluble in some organic solvents like DMSO, chloroform
    Melting Point Typically in a certain temperature range (experimental determination needed)
    Pka Values related to acidic/basic groups in the molecule (experimental determination required)
    Density Experimental determination needed for accurate value
    Uv Vis Absorption Absorption peaks in specific wavelength regions (experimental determination required)

    As an accredited Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of Ethyl 2-(3 - Cyano - 4 - Hydroxyphenyl)-4 - Methyl - 1,3 - Thiazole - 5 - Carboxylate in sealed container.
    Shipping Ethyl 2-(3 - Cyano - 4 - Hydroxyphenyl)-4 - Methyl - 1,3 - Thiazole - 5 - Carboxylate is shipped in accordance with chemical safety regulations. Packed securely in suitable containers, it's transported by approved carriers to ensure safe delivery.
    Storage Ethyl 2-(3 - Cyano - 4 - Hydroxyphenyl)-4 - Methyl - 1,3 - Thiazole - 5 - Carboxylate should be stored in a cool, dry place away from direct sunlight. Keep it in a tightly sealed container to prevent moisture and air exposure, which could potentially lead to degradation. Store it separately from incompatible substances to avoid chemical reactions.
    Application of Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate

    How Does This Ester Intermediate Dictate Critical Impurity Profiles in Febuxostat Manufacturing?

    In the established industrial synthesis of febuxostat – a non-purine xanthine oxidase inhibitor governed by monographs such as USP 43 and EP 10.3 – ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate functions as the discrete branch-point that bifurcates the impurity network. The downstream O-alkylation with isobutyl bromide (or isobutyl chloride under phase-transfer conditions) at the free phenolic hydroxyl is kinetically sensitive to the active electrophile stoichiometry. Production-scale batch records indicate that the molar input of isobutyl bromide relative to the title ester must be held within 1.12–1.18 equivalents when the reaction is conducted in anhydrous N,N-dimethylformamide with milled potassium carbonate (2.5–3.0 equivalents) and a catalytic quantity of potassium iodide (0.05–0.08 equivalents). Straying below 1.12 equivalents elevates residual phenolic starting material above the 0.10% threshold specified in the febuxostat monograph for unspecified impurities, while a charge exceeding 1.25 equivalents accelerates the formation of the O,N-dialkylated quaternary ammonium by-product, which co-crystallises with the desired febuxostat ethyl ester intermediate and requires subsequent enzymatic or resin-based scavenging. The process is executed in glass-lined reactors (DIN 28136 Part 1) equipped with retreat-blade impellers, maintaining a jacket temperature of 48–52 °C for 16–20 hours under a nitrogen sweep of 0.2–0.5 bar(g). Post-reaction, the slurry is filtered through a 0.5-micron sparkler filter charged with acid-washed Celite® to remove potassium salts, and the filtrate is concentrated in a wiped-film evaporator operating at 45 °C and 8–12 mbar. The regulatory framework for this transformation embraces ICH Q7 (GMP for API), 21 CFR 210/211, and the EMA Guideline on the Chemistry of Active Substances; residual solvent levels are monitored against ICH Q3C limits for DMF (class 2, 880 ppm). The terminal refined product is febuxostat USP, which is subsequently micronised for tablet compression to D90 ≤ 15 µm.

    Direct Hydrolytic Cleavage to the Free Carboxylic Acid Intermediate. Alkaline saponification of the ethyl ester represents the most direct route to 2-(3-cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylic acid, a versatile entry point for amide prodrugs and co-crystal screens. Batch-to-batch variability at scale originates almost entirely from the water content of the sodium hydroxide charge. The preferred stoichiometry applies 2.8–3.2 molar equivalents of NaOH relative to ester, delivered as a 15% w/w aqueous solution into a refluxing mixture of the ester in ethanol (ratio 1:8 m/v). The hydrolysis exotherm demands a controlled dosing rate such that the internal temperature does not overshoot 78 °C; the reflux is maintained for an additional 4–6 hours until in-process HPLC (C18 column, 254 nm) shows ester peak area ≤ 0.5%. Acidification with 6M hydrochloric acid to pH 2.3–2.5 precipitates the free acid, which is isolated via a horizontal peeler centrifuge, washed with deionised water until effluent conductivity drops below 10 µS/cm, and dried in a double-cone rotary vacuum dryer at 55–60 °C and ≤ 20 mbar for 12 hours. Applicable quality management benchmarks include ISO 9001:2015 and, where the acid is shipped for further API steps, ICH Q11 approach for starting material designation. The terminal material is a white to off-white crystalline powder used directly in early-phase clinical candidate synthesis or as a reference standard for impurity profiling.

    Process Parameter Matrix Across Primary Downstream Transformations
    TransformationKey Reagent Ratio (mol/mol)Critical Temperature WindowpH/Protic Control Requirement
    O-Alkylation to febuxostat ethyl esterester : isobutyl bromide = 1 : 1.12–1.1848–52 °CKF < 0.05% w/w (anhydrous)
    Ester saponification to free acidester : NaOH = 1 : 2.8–3.276–78 °C (reflux ramp)Final isolation pH 2.3–2.5
    Azo-coupling for disperse dyecoupler : diazonium salt ≈ 1 : 0.98–1.000–5 °C (diazotisation), 5–10 °C (coupling)Coupling pH 4.0–4.5 (acetate buffer)
    Transesterification to methyl ester analogester : sodium methoxide = 1 : 0.15–0.2560–64 °CMethanol moisture < 0.10%

    When discovering next-generation heterocyclic dyes for high-temperature polyester exhaust dyeing, formulators exploit the nucleophilic phenolic hydroxyl group of ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate as a coupling site for diazonium salts derived from substituted anilines. The cyano and carboxyester moieties function cooperatively as strong electron-withdrawing auxochromes, shifting the absorption maximum bathochromically into the 540–600 nm region and improving the dye’s sublimation fastness on polyethylene terephthalate fibre. In a representative diazotisation-coupling sequence validated on 1000-litre plant scale, the diazonium component – typically 2-chloro-4-nitroaniline or 2,6-dichloro-4-nitroaniline – is prepared by adding a 30% w/w aqueous sodium nitrite solution (0.99 molar equivalent) to the aniline suspension in 30% hydrochloric acid at 0–2 °C, with excess nitrite decomposition managed by sulfamic acid addition to a spot-test negative on starch-iodide paper. The coupling component charge ratio consistently targets 1 mole of the title ester to 0.98–1.00 mole of diazonium ion; off-setting the coupler molar excess by more than 2% results in residual diazonium-induced tar that darkens the presscake and reduces the dye’s tinctorial strength by 8–15%. Coupling is conducted in a jacketed vessel with a two-stage marine-type impeller at 120–150 rpm, keeping the internal temperature at 5–8 °C and maintaining pH 4.0–4.5 via metered 20% sodium acetate solution. After a post-coupling stir period of 3–4 hours, the dye is isolated by filter pressing, washed to a chloride ion content below 50 ppm (conductometric endpoint), and dried in an air-fluidised bed at 70–75 °C inlet temperature. The raw dye is then standardised with dispersing agents (lignosulfonate or naphthalene sulfonate condensate) to a strength of 200% or 300% in a horizontal bead mill (zirconia beads 0.4–0.6 mm) before spray drying. Compliance obligations span OEKO-TEX® Standard 100 Annex 4 (limit for 2,4-dinitrotoluene < 50 mg/kg), the ZDHC Manufacturing Restricted Substances List v3.0, REACH (EC) 1907/2006 Annex XVII entries on azo colorants, and ISO 105-C06:2010 wash fastness testing. The terminal output is a reddish-blue to violet disperse dye powder possessing high build-up properties on polyester when applied at 130 °C in a high-temperature jet dyeing machine.

    If Selective Crystallisation Is Required to Control Febuxostat Polymorph B Formation

    The title ethyl ester is the direct penultimate intermediate in a route designed to lock the final febuxostat crystal lattice into the thermodynamically stable polymorph B, which exhibits a melting endotherm of 206–208 °C by differential scanning calorimetry (10 °C/min, nitrogen purge) and is the preferred solid form listed in the innovator drug master file. After O-alkylation and subsequent alkaline hydrolysis – now optionally using lithium hydroxide in tetrahydrofuran-water (4:1 v/v) at 20–25 °C to minimise cyano hydration – the liberated carboxylic acid is not isolated as a dry solid but is phase-switched into ethyl acetate, dried over anhydrous magnesium sulfate, and treated with a controlled water activity established by storing the organic solution over a saturated potassium chloride slurry (aw0.84) for 8–10 hours at 22 ± 1 °C. Polymorph B nucleation is triggered by seeding with 0.3–0.5% w/w of previously characterised form B microcrystals during a linear cooling profile from 50 °C to 5 °C at a rate of 0.1 °C/min in a 200-litre un-baffled crystalliser equipped with a retreat-curve impeller. The addition ratio of ethyl acetate to the crude acid is critical: less than 8 mL/g risks oiling-out of the supersaturated solute, whereas volumes exceeding 14 mL/g reduce the yield below 72%. Regulatory compliance for this polymorph-specific pathway is tethered to ICH Q6A (decision tree #4 on polymorphism), and the polymorphic purity must exceed 99.5% as confirmed by X-ray powder diffraction using Cu Kα radiation (λ = 1.5406 Å) with characteristic peaks at 2θ = 5.2°, 10.5°, 15.8°. The terminal product is febuxostat polymorph B, formulated directly into film-coated tablets at 40 mg and 80 mg strengths under ICH M3(R2) impurity qualification thresholds.

    Varying the Ester Moiety for Structure-Activity Relationship Exploration in Non-Purine Xanthine Oxidase Inhibitors

    Medicinal chemistry campaigns focused on expanding the non-purine xanthine oxidoreductase inhibitor pharmacophore utilise the title ethyl ester as a common scaffold for transesterification and direct amidation, bypassing the need for prior ester hydrolysis. Alkoxide-catalysed transesterification with primary alcohols – methanol, n-propanol, or 2-methoxyethanol – in the presence of the corresponding sodium alkoxide (0.15–0.25 equivalents) at reflux provides the homologous alkyl esters in 82–94% isolated yield after aqueous workup and trituration with heptane. Reaction monitoring by 1H NMR (disappearance of the ethyl quartet at δ 4.35 ppm) is preferred over TLC owing to minimal Rf displacement in silica gel systems. The free carboxylic acid intermediate can be activated with 1.05 equivalents of 1,1′-carbonyldiimidazole in dry tetrahydrofuran at 0–5 °C for subsequent coupling with aliphatic amines to generate amide libraries; this procedure avoids the racemisation-prone mixed anhydride method and is compatible with automated parallel synthesis platforms employing 8 mL vials and bar-coded tracking. Each synthesised analog is screened for bovine milk xanthine oxidase inhibition under the semi-automated protocol of Worthington Biochemical Corp. at substrate (xanthine) concentrations of 50 µM. The downstream process handling in vitro DMPK assessment – microsomal stability (NADPH-regenerating system, 37 °C) and CYP 3A4/2D6 isoform profiling – falls under the study design considerations of EMA Guideline on Investigation of Drug Interactions (CPMP/EWP/560/95). The terminal output is a series of ethyl, methyl, propyl esters and primary amide derivatives employed as tool compounds in lead optimisation, with all solid samples packaged under argon in amber vials and stored at −20 °C to suppress oxidative degradation of the phenolic ring.

    Compliance and Regulatory Coverage by Application Segment
    Application SegmentRelevant Standard/GuidelineProduct Registration Framework
    Febuxostat API intermediateICH Q7, USP ⁅43⁆ Monograph, EP 10.3US DMF Type II, CEP (EDQM)
    Carboxylic acid intermediate for prodrugsISO 9001:2015, ICH Q11 (starting material)EU REACH (as transported isolated intermediate)
    Heterocyclic disperse dye synthesisOEKO-TEX® 100, ZDHC MRSL, REACH Annex XVIIK-REACH pre-registration, SCIP Database entry
    Polymorph-controlled febuxostat crystallisationICH Q6A, Ph.Eur. 2.9.33 (XRD)ASMF (formerly EDMF)
    Medicinal chemistry SAR library synthesisEMA CPMP/EWP/560/95, GLP Directive 2004/10/ECLaboratory-scale, non-GMP; export under TSCA R&D exemption
    Free Quote

    Competitive Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    Without preamble, the molecule enters the synthetic record as a crystalline, non-hygroscopic solid that serves as the penultimate building block in one of the dominant process routes to the xanthine oxidase inhibitor febuxostat. Known systematically as ethyl 2-(3-cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate and assigned CAS 161798‑01‑2, the compound presents a molecular weight of 288.32 g·mol⁻¹ and a molecular formula of C₁₄H₁₂N₂O₃S. Its immediate structural fingerprint—a free phenolic hydroxyl *ortho* to an electron‑withdrawing nitrile substituent on the phenyl ring, coupled with an ethyl ester at the thiazole 5‑position—dictates both its reactivity advantage and its principal handling vulnerability. Off‑white to pale‑yellow microcrystals of melting range 214–218 °C (determined by differential scanning calorimetry per ASTM E794‑06) are typical of material purified by recrystallisation from ethanol/water mixtures. The free phenol remains the operational discriminator: downstream amidation with 2‑aminothiazole‑4‑carboxamide proceeds without requiring a final deprotection step, collapsing the synthetic sequence by one unit operation relative to routes that carry a labile *O*‑alkyl protecting group such as isobutyl through the ester precursor.

    Purity and Physical Specifications Are Defined by Orthogonal Analytical Methods

    Routine lot release is governed by a combination of chromatographic, titrimetric, and spectrometric assays. HPLC peak‑area purity on a C18 column (mobile phase acetonitrile:phosphate buffer pH 3.0) must exceed 99.0 area‑% with individual impurity ceilings set at ≤0.10 % for the des‑cyano analogue and ≤0.15 % for the 5‑carboxylic acid hydrolysis product. UV detection is performed at 254 nm; response factors for the two persistent process impurities are calibrated against isolated, characterised reference standards whose structures are confirmed by ¹H‑NMR (400 MHz, DMSO‑*d*₆) and high‑resolution mass spectrometry. Water content, a direct proxy for residual humidity after vacuum tray drying at 45 °C and ≤10 mbar, is capped at ≤0.50 % w/w by Karl Fischer titration (Metrohm coulometer, Hydranal‑Composite 5 reagent). Lots exceeding 0.70 % are reprocessed because free water accelerates ester hydrolysis during heated amidation stages when the compound is dissolved in N‑methyl‑2‑pyrrolidone (NMP) at 130–140 °C. Residual solvent profiles are mapped to the ICH Q3C Option‑2 limits: ethanol ≤5000 ppm, ethyl acetate ≤5000 ppm, and *N,N*‑dimethylformamide (when employed as a crystallisation co‑solvent) ≤880 ppm. Analysis is executed by headspace GC‑FID following USP ⟨467⟩ Procedure A, with a DB‑624 column and a split ratio of 1:5. Loss on drying (105 °C to constant mass) routinely lands below 0.30 % and is documented as an in‑process check but not a release criterion once moisture‑specific methods are established.
    Typical Batch‑Release Specification
    AttributeMethod / StandardAcceptance Criterion
    HPLC purityIn‑house gradient method; column L1≥99.0 area‑%
    Melting rangeASTM E794‑06 (DSC onset)214–218 °C
    Water (KF)USP ⟨921⟩ Method Ic≤0.50 % w/w
    Residual EtOHUSP ⟨467⟩ Procedure A≤5000 ppm
    Residual DMFUSP ⟨467⟩ Procedure A≤880 ppm
    5‑Carboxylic acid (impurity)HPLC; relative retention ≈1.18≤0.15 area‑%

    Which Downstream Reaction Sequences Benefit from This Intermediate?

    The compound is not a direct API precursor in the sense of a final‑step coupling; rather, it is the key building block for febuxostat process patents that rely on a thiazole‑amide bond formation. The free phenolic hydroxyl activates the phenyl ring for nucleophilic aromatic substitution when the nitrile group is simultaneously present, yet the ester at the 5‑position of the thiazole must first be converted to the corresponding carboxylic acid or directly amidated. The most widely documented protocol—the one practised in multi‑hundred‑kilogram campaigns—dissolves the dry ester in NMP, introduces 1.05–1.15 equivalents of 2‑aminothiazole‑4‑carboxamide, and heats the mixture in the presence of potassium carbonate or sodium methoxide as a base. Amidation proceeds at 130–140 °C for 6–8 hours; the liberated ethanol is partially distilled to drive the equilibrium. Process analytical technology (ReactIR with a diamond ATR probe) tracks the disappearance of the ester carbonyl stretch at 1712 cm⁻¹ and the growth of the amide I band at 1658 cm⁻¹. Because the free phenol remains unprotected, the reaction generates febuxostat directly after acidification and recrystallisation from methanol/water, eliminating the hydrogenolysis or Lewis‑acid cleavage steps required when the *O*‑isobutyl or *O*‑benzyl congener is employed. This economy of steps has translated, in production‑scale campaigns using 5000‑L glass‑lined reactors, to an overall yield improvement of 8–12 percentage points when benchmarked against the isobutyl‑protected route under identical equipment constraints. The unprotected phenol does introduce a side‑reaction vector: under prolonged thermal exposure in the presence of residual alkali, the ethyl ester at the thiazole can undergo transesterification with the phenolic –OH to form oligomeric esters, detectable as a high‑molecular‑weight shoulder in GPC. This pathway is suppressed by strict control of the base stoichiometry (< 1.20 eq) and by a nitrogen sweep that removes liberated ethanol quickly. At the pilot scale, a wiped‑film evaporator operating at 90 °C and 20 mbar has been used to strip ethanol from the reaction mass continuously, reducing dimeric by‑product levels to ≤0.3 area‑%.

    When Elevated Humidity Introduces Ester Hydrolysis Risk, Storage Protocols Become Critical

    The moisture sensitivity of the thiazole‑5‑carboxylate ester is not pronounced at ambient conditions; however, exposure to relative humidity above 65 % at 25 °C over a period of 14 days has been observed to increase the 5‑carboxylic acid impurity from 0.08 % to 0.45 % in unpackaged powder stored in an open‑top container inside a stability chamber (data generated using a Memmert HPP 110 constant climate chamber). Consequently, primary packaging for commercial shipment consists of double low‑density polyethylene liners sealed inside a foil‑laminate drum with a silica‑gel desiccant sachet rated for 500 g water absorption. At the point of use, if the ambient dew point exceeds 10 °C, the compound is transferred under a nitrogen blanket into a glove‑box purged to < 1000 ppm moisture content. Campaign reports from a manufacturer operating a 30‑m³ cleanroom classified as ISO 14644‑1 Class 8 indicate that lots with a Karl Fischer value of < 0.35 % yielded febuxostat meeting the USP monograph (NLT 98.0 % and NMT 102.0 % on dried basis) without re‑processing, whereas lots exceeding 0.65 % water showed a 1.5‑2.0 % yield drop attributed to parallel ester hydrolysis during the initial heating phase. Pre‑drying of non‑compliant material is feasible but must be approached with caution. Static vacuum drying at 40–45 °C for 8–12 hours restores a water content below 0.40 % without thermally degrading the product, provided the condenser is maintained at −15 °C to capture water efficiently. Fluid‑bed drying has not been adopted in production because the mechanical attrition generates fines that alter bulk density and complicate volumetric feeding into the NMP charge. The tapped density of the recrystallised material is typically 0.55–0.65 g·cm⁻³; lots that drop below 0.48 g·cm⁻³ are correlated with excessive fine generation during centrifuge unloading and are re‑slurried in ethanol to restore particle size distribution.

    Comparative Reactivity Profiles Against O‑Alkyl Analogues

    The most commonly encountered structural comparator is ethyl 2‑(3‑cyano‑4‑isobutoxyphenyl)‑4‑methyl‑1,3‑thiazole‑5‑carboxylate (CAS 160844‑75‑7), in which the phenolic oxygen is masked as an isobutyl ether. That compound can be synthesised by alkylating the free phenol with isobutyl bromide under basic conditions, and it offers the notable advantage of improved solubility in low‑boiling solvents such as ethyl acetate (≈50 mg·mL⁻¹ at 25 °C versus < 2 mg·mL⁻¹ for the free phenol). This solubility premium simplifies pilot‑scale chromatography and extractive work‑ups, but it defers the removal of the protecting group to the final febuxostat molecule or an advanced intermediate. Reported deprotection methods include boron tribromide in dichloromethane at −10 °C or concentrated HBr in acetic acid—reagents that introduce a separate waste stream and require corrosion‑resistant equipment. A full‑cost analysis conducted on a 200‑kg batch scale (base case febuxostat price ≈$800/kg) indicated that the unprotected phenol route reduced raw‑material and waste‑disposal costs by approximately 22 %, even after accounting for the additional nitrogen‑blanketing infrastructure. Nonetheless, where a manufacturing site lacks the capability to handle moisture‑sensitive intermediates or cannot implement nitrogen inertisation in existing reactor trains, the isobutyl ether remains the fall‑back option. A second comparator is the corresponding 5‑carboxylic acid, 2‑(3‑cyano‑4‑hydroxyphenyl)‑4‑methyl‑1,3‑thiazole‑5‑carboxylic acid, which can be obtained by saponification of the ethyl ester. Direct use of the acid in an amide coupling with a carbodiimide (e.g., EDC·HCl) is documented in several laboratory‑scale febuxostat syntheses, but the homogeneous coupling produces a ureide by‑product that is notoriously difficult to purge below 0.10 % in the final API. Industrial campaigns have therefore conserved the ethyl ester as the penultimate isolable intermediate, sacrificing the extra saponification step for a cleaner impurity profile in the downstream amidation. In high‑shear melt amidation processes under microwave irradiation, the free phenol ester has exhibited a reaction half‑life of 12–15 min at 150 °C, whereas the isobutyl‑protected ester required 22–25 min to reach the same conversion, measured by inline Raman monitoring (785 nm laser). This observation is attributed to the electron‑withdrawing character of the unprotected hydroxyl, which renders the adjacent thiazole carbonyl more electrophilic.
    Process‑Relevant Comparison of Thiazole Ester Intermediates
    ParameterEthyl ester with free –OHEthyl ester with –O‑isobutyl
    Amidation yield (isolated) at 200‑kg scale79–82 % after crystallisation67–71 % after deprotection and crystallisation
    Total synthetic steps from 4‑hydroxy‑3‑nitrobenzonitrile34
    Corrosive reagents avoidedBBr₃, HBr/AcOHNone (requires BBr₃ or HBr)
    Solubility in EtOAc at 25 °C< 2 mg·mL⁻¹~50 mg·mL⁻¹
    Moisture sensitivity threshold for yield lossWater >0.65 % w/wWater >1.0 % w/w
    The handling protocol for the free phenol intermediate diverges sharply from that of its O‑alkyl congeners in one additional respect: exposure to ultraviolet light, particularly in the 300–350 nm range, induces a slow photoisomerisation of the thiazole ring, observable as a bathochromic shift in the UV‑Vis spectrum and an increase of the 0.15 RRT impurity peak. Amber glass or opaque HDPE packaging with UV‑blocking additives (carbon black loading ≥2.5 %) is required for shipment across equatorial routes where container temperatures can exceed 50 °C. Stability studies conducted under ICH Q1B conditions (1.2 million lux·h visible light and 200 W·h·m⁻² UV) confirmed that unprotected bulk powder darkened from off‑white to brown when stored in clear borosilicate, whereas amber borosilicate packaging held the purity loss to < 0.15 % over the duration of the study. Consequently, validation batches for febuxostat manufacturers routinely include a photostability checkpoint on the incoming intermediate.